Case Counts

The Infectious Diseases & Outbreaks Division monitors the incidence and prevalence of communicable, zoonotic, and environmentally-related human diseases. This table summarizes cases reported over the last five years, as well as the cases reported year-to-date this year and last year. 

 

Cases Reported Year-to-Date*

Totals by Year Reported

Condition

2019

2018

% Change

2018

2017

2016

2015

2014

Acute Flaccid Myelitis

1

0

--

4^

--

--

--

--

Anthrax

0

0

--

0^

0

0

0

0

Arboviral Diseases (includes West Nile virus, Zika virus, and other Arboviral diseases)

0

1

-100.0%

31

67

60^

10^

23^

Babesiosis

0

0

--

0

1

0

2

1

Botulism

0

0

--

0

0

1

1

0

Brucellosis

3

0

--

1

0

0

2

0

Campylobacteriosis

153

145

5.5%

783

790

692

589^

255

Cholera

0

0

--

0

0

0

0

0

Coccidioidomycosis

3

0

--

0

--

--

--

--

Cryptosporidiosis

42

37

13.5%

152

189

334

261

147

Dengue

0

0

--

3

0

5

3^

3

E. coli, shiga toxin-producing (includes O157: H7)

24

12^

100.0%

129^

31

39

40

41^

Ehrlichiosis/Anaplasmosis

0

1

-100.0%

24

17

21

18

19

Giardiasis

31

41

-24.4%

217

191

234

188

182

Hansen's Disease (Leprosy)

0

0

--

0

1

1

1

0

Hantavirus Pulmonary Syndrome

0

0^

--

0^

--

--

--

--

Hemolytic uremic syndrome (HUS)

2

0

--

2

0

6

3

1

Influenza-associated pediatric mortality

1

2

-50.0%

2

1

0

1

1

Legionellosis

9

2

350.0%

76

66

63

59

62

Leptospirosis

0

1

-100.0%

1

0

0

0

1

Listeriosis

0

2

-100.0%

11

5

8

5

9

Lyme disease

2

8

-75.0%

34

39^

38

25

17

Malaria

0

0

--

9

8

11

11

14^

Novel Influenza A virus infection

0

0

--

0

0

0

0

0^

Paratyphoid Fever

0^

0^

--

6^

3

9

0

0

Plague

0

0

--

0

0

0

0

0

Psittacosis

0

0

--

0

0

0

0

0

Q fever

1

0

--

3

0

1

0

2

Rabies, animal

9

7

28.6%

55

51

77

83

78

Rabies, human

0

0

--

0

0

0

0

0

Salmonellosis

125

121^

3.3%

1186^

1130^

1276

1151

1165

Severe Acute Respiratory Syndrome-associated Coronavirus (SARS-CoV)

0

0

--

0

0

0

0

0

Shigellosis

48

62

-22.6%

320

247^

239

680

516

Spotted Fever Rickettsiosis

45

53

-15.1%

675

671

453

288

220

Toxic Shock Syndrome (non-streptococcal)

0

0^

--

0^

--

--

--

--

Trichinellosis (Trichinosis)

0

0

--

0

0

0

0

0^

Tularemia

0

0

--

0

1^

1

0

0

Typhoid fever

0^

0

--

1

1

0

0

2

VISA (Staphylococcus aureus, vancomycin-intermediate)

0

0

--

1

4

3

2

2

VRSA (Staphylococcus aureus, vancomycin-resistant)

0

0

--

0

0

0

0

0

Vibriosis (non-Cholera)

4

3

33.3%

38

26^

31

19

20

Yellow Fever

0^

0

--

0

0

0

0

0

Other Investigations

0

0

--

0

0

0

0

27

Total

503

498

1.0%

3925

2097

3543

2840

2730

NOTE: Counts include finalized investigations among Alabama residents as of April 3, 2019. The Other investigations category includes a variety of conditions or events that have been investigated, but are not reportable in Alabama or do not fall into any other category (e.g., Histoplasmosis, Streptococcal toxic-shock syndrome, Yersiniosis, etc.). To see case counts for conditions investigated by other divisions, please see the following websites: Tuberculosis, Immunizations, Sexually Transmitted Diseases, and HIV/AIDS.

*Through MMWR Week 13 (week ending March 30, 2019), as compared to the same time period in the previous calendar year.

^The case definition was updated this year for this condition.

 



Page last updated: April 3, 2019